About
Polycythemia can lead to high blood pressure and, in certain scenarios, an increased risk of stroke and heart attack. It’s linked to an increased chance of high blood pressure and heart health conditions. Polycythemia is also a risk for transgender men taking testosterone as hormone replacement therapy (HRT). This risk can be higher with unregulated testosterone injections, such as those people use for bodybuilding. Polycythemia makes it harder for your heart to circulate blood throughout your body, and it can lead to complications such as high blood pressure or stroke.Hydration, diet, physical activity, smoking cessation, stress management, and regular health check-ups collectively contribute to a healthier blood profile and overall well-being. Smoking has been linked to increased red blood cell production and can exacerbate the condition. Proper hydration helps to dilute the blood, reducing its viscosity and easing the heart’s workload in pumping blood throughout the body.
Therapeutic phlebotomy is an essential and effective intervention for managing polycythemia in TRT patients. This includes regular consultations with healthcare providers, adherence to TRT protocols, and lifestyle modifications that support overall health and well-being. While therapeutic phlebotomy is effective in managing polycythemia, it should be considered part of a broader health management strategy. It allows patients to continue their TRT regimen while addressing the increased RBC count that can accompany this therapy. For patients on TRT, therapeutic phlebotomy serves as a vital tool in managing the side effect of polycythemia. Under medical supervision, a specified amount of blood is drawn from the patient.
Increased red blood cell production requires more iron, so iron stores can get exhausted if your red blood cell production increases. Testosterone increases red blood cell production. At Nervana Medical, we combine hormone optimization with nutrient repletion, including IV iron and personalized supplementation protocols, to ensure patients achieve not only the benefits of testosterone but also the optimal oxygen-carrying capacity of their blood. It may seem counterintuitive to give iron to someone with elevated hematocrit, but studies confirm that iron repletion is safe and necessary in patients with secondary polycythemia who are iron deficient (Lui et al., 2017; Auerbach et al., 2025). Continued monitoring is essential to ensure hematocrit remains within safe limits and to adjust therapy as needed.
While this is technically a treatment, it also acts as prevention by stopping complications from developing. In these cases, prevention means being flexible with treatment. Sometimes, despite best efforts, a patient’s blood counts continue to rise. Lifestyle habits can play a big role in whether a man develops polycythemia during TRT. By catching rising numbers early, action can be taken before dangerous symptoms or complications develop. Once therapy begins, follow-up tests should be done about every three months during the first year.